Yantai Zhenghai Bio-Tech Co Ltd (300653) - Total Liabilities
Based on the latest financial reports, Yantai Zhenghai Bio-Tech Co Ltd (300653) has total liabilities worth CN¥90.38 Million CNY (≈ $13.23 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 300653 cash generation efficiency to assess how effectively this company generates cash.
Yantai Zhenghai Bio-Tech Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Yantai Zhenghai Bio-Tech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 300653 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Yantai Zhenghai Bio-Tech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yantai Zhenghai Bio-Tech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Guangdong Guanghong Holdings Co Ltd
SHE:000529
|
China | CN¥3.60 Billion |
|
Gansu Dunhuang Seed Co Ltd
SHG:600354
|
China | CN¥858.53 Million |
|
Shenzhen Keanda Electronic Techno
SHE:002972
|
China | CN¥206.27 Million |
|
MiCo Ltd
KQ:059090
|
Korea | ₩1.12 Trillion |
|
ACNB Corporation
NASDAQ:ACNB
|
USA | $2.81 Billion |
|
Shandong Meichen Science & Technology Co Ltd
SHE:300237
|
China | CN¥5.28 Billion |
|
Shenzhen Huakong Seg Co Ltd
SHE:000068
|
China | CN¥3.02 Billion |
|
S.C. CHIMCOMPLEX S.A.
RO:CRC
|
Romania | RON990.32 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Yantai Zhenghai Bio-Tech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300653 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yantai Zhenghai Bio-Tech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below shows the annual total liabilities of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥91.33 Million ≈ $13.36 Million |
-13.64% |
| 2023-12-31 | CN¥105.76 Million ≈ $15.48 Million |
-13.17% |
| 2022-12-31 | CN¥121.80 Million ≈ $17.82 Million |
-15.21% |
| 2021-12-31 | CN¥143.65 Million ≈ $21.02 Million |
-9.55% |
| 2020-12-31 | CN¥158.82 Million ≈ $23.24 Million |
+20.26% |
| 2019-12-31 | CN¥132.06 Million ≈ $19.33 Million |
+140.17% |
| 2018-12-31 | CN¥54.99 Million ≈ $8.05 Million |
+15.44% |
| 2017-12-31 | CN¥47.63 Million ≈ $6.97 Million |
+53.77% |
| 2016-12-31 | CN¥30.98 Million ≈ $4.53 Million |
+47.86% |
| 2015-12-31 | CN¥20.95 Million ≈ $3.07 Million |
+12.11% |
| 2014-12-31 | CN¥18.69 Million ≈ $2.73 Million |
-61.43% |
| 2013-12-31 | CN¥48.46 Million ≈ $7.09 Million |
-50.66% |
| 2012-12-31 | CN¥98.21 Million ≈ $14.37 Million |
-- |
About Yantai Zhenghai Bio-Tech Co Ltd
Yantai Zhenghai Biotechnology Co., Ltd. engages in the research and development, production, and sales of bioregenerative medical materials in China. The company offers oral repair membranes, absorbable dura mater patches, active biological bones, skin repair membranes, bone repair materials, surgical packing sponges, phosphoric acid etchant, dental pit and fissure sealant, light-curing composite… Read more